Tirzepatide and Exercise for Muscle Health in Overweight Adults
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study tests whether combining a newer weight-loss medication (tirzepatide) with a structured exercise program helps improve muscle strength and function in people who are overweight or obese. Researchers will measure changes in muscle quality and physical fitness over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your doctor has recently prescribed tirzepatide (a GLP-1/GIP medication) for weight management
- Your BMI is 30 or higher, OR your BMI is 27–29.9 with another health condition like high blood pressure or high cholesterol
- You are between 18 and 65 years old
- You do not have type 1 or type 2 diabetes
- You have not had major arm or leg surgery or injury in the past 6 months
- You are able to safely do resistance exercises like weightlifting or strength training
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether tirzepatide can improve how your body handles fat (especially in people with overweight or obesity) and reduce fat-related “lipotoxicity.” It may help with body fat function and related health markers, but you must meet specific health and medication rules.
This study tests a medication called tirzepatide (a type of GLP-1 drug) to see how it affects muscle and bone health during weight loss. It is for people with obesity who are not menopausal and do not have diabetes or bone disease.
This study tests if tirzepatide helps people with obesity lose weight, whether or not they have type 2 diabetes. It aims to see how safe and effective the drug is.
This trial tests if tirzepatide is more effective than standard obesity treatments for adults who have a BMI between 30 and 35 and one weight-related health condition, but do not have diabetes. The goal is to help you lose weight.
This study tests whether a GLP-1 medication (a type of drug that helps with weight and blood sugar) can improve lung function and muscle strength in people with COPD who are overweight or have weight-related health problems. It may offer a new way to treat both breathing and muscle issues in COPD.
This study tests a new medication called tirzepatide, given at carefully adjusted doses, to help people with obesity lose weight while reducing unwanted side effects. Tirzepatide is a newer injectable medicine that helps control appetite and blood sugar.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.